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Abstract
Background:  Borrelia burgdorferi has limited biosynthetic capabilities and must scavenge N-
acetylglucosamine (GlcNAc), an essential component of the microbial cell wall, from the
surrounding environment. Spirochetes cultured in the absence of free GlcNAc exhibit biphasic
growth; however, addition of chitobiose (a dimer of GlcNAc) substitutes for free GlcNAc resulting
in a single exponential phase. We evaluated the effect of RpoS and RpoN, the only alternative sigma
factors in B. burgdorferi, on biphasic growth and chitobiose utilization in the absence of free GlcNAc.
In addition, we investigated the source of GlcNAc in the second exponential phase.
Results: By comparing the growth of wild-type cells to insertional mutants for rpoS and rpoN we
determined that RpoS, but not RpoN, partially regulates both biphasic growth and chitobiose
utilization. The rpoS mutant, cultured in the absence of free GlcNAc, exhibited a significant delay
in the ability to initiate a second exponential phase compared to the wild type and rpoS
complemented mutant. Expression analysis of chbC, which encodes the membrane-spanning
protein of the chitobiose phosphotransferase system, suggests the delay is due to the inability of
the rpoS mutant to up regulate chbC. Furthermore, supplementing GlcNAc starved cultures with
high concentrations (75 or 150 μM) of chitobiose resulted in biphasic growth of the rpoS mutant
compared to a single exponential phase for the wild type and rpoS complemented mutant. In
contrast, growth of the rpoN mutant under all conditions was similar to the wild type. 5' Rapid
amplification of cDNA ends (5' RACE) revealed the transcriptional start site for chbC to be 42 bp
upstream of the translational start site. Analysis of the chbC promoter region revealed homology
to previously described RpoD and RpoS B. burgdorferi p r o m o t e r s .  W e  a l s o  d e t e r m i n e d  t h a t
yeastolate, a component of the growth medium (BSK-II), is not essential for second exponential
phase growth.
Conclusion: Together these results suggest that RpoD and RpoS, but not RpoN, regulate biphasic
growth and chitobiose utilization in B. burgdorferi by regulating the expression of the chitobiose
transporter (chbC). The data also demonstrate that the second exponential phase observed in wild-
type cells in the absence of free GlcNAc is not due to free chitobiose or GlcNAc oligomers present
in the medium.
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Background
Borrelia burgdorferi is the etiologic agent of Lyme disease,
the most common vector-borne disease in the United
States. The spirochete is maintained in an enzootic cycle,
alternating between a tick vector (Ixodes scapularis) and
vertebrate host. Uninfected larval ticks acquire B. burgdor-
feri after feeding on a vector-competent host, and spiro-
chetes colonize and persist within the tick midgut for
months as the tick molts to the nymphal stage [1]. In the
infected-unfed tick, B. burgdorferi is associated with the
midgut epithelium, existing in a non-replicative state in a
nutrient poor environment. When infected nymphs begin
to feed, the number of spirochetes increases as nutrients
required for growth become more abundant [2]. The spi-
rochetes move from the midgut of the feeding tick to the
hemolymph and then to the salivary glands where they
can be transferred to a naïve host, a process that occurs no
earlier than 24 hours after tick attachment [3].
Small rodents or birds are the primary reservoirs of B.
burgdorferi; however, I. scapularis occasionally transmits
the bacterium to larger vertebrates, including humans [1].
Upon infection in humans, spirochetes disseminate from
the site of inoculation and may move to tissues other than
the skin resulting in numerous clinical manifestations [1].
Symptoms of the primary infection are typically observed
days to weeks after the tick bite and include flu-like symp-
toms that may be accompanied by a macular rash known
as erythema migrans. If left untreated other symptoms
may present months after inoculation, resulting in arthri-
tis, myocarditis, and/or lesions of the peripheral and cen-
tral nervous systems [1].
While B. burgdorferi has evolved to survive in vastly differ-
ent environments, it has limited biosynthetic capabilities
and must obtain most nutrients from its surrounding
environment [4,5]. N-acetylglucosamine (GlcNAc) is an
essential component of peptidoglycan, the rigid layer
responsible for strength of the microbial cell wall. Many
bacteria can synthesize GlcNAc de novo; however, B. burg-
dorferi must import GlcNAc as a monomer or dimer (chi-
tobiose) for cell wall synthesis and energy. Therefore, B.
burgdorferi is normally cultured in vitro in the presence of
free GlcNAc [6].
In the tick much of the GlcNAc is polymerized in the form
of chitin, as this is the major component of the tick
exoskeleton. In addition, chitin is an integral part of the
peritrophic matrix that encases the blood meal during and
after tick feeding. This membrane functions as a permea-
bility barrier, enhances digestion of the blood meal, and
protects the tick midgut from toxins and pathogens [7].
GlcNAc oligomers released during remodeling of the per-
itrophic matrix may be an important source of GlcNAc for
B. burgdorferi in the nutrient limiting environment of the
unfed-infected tick midgut [8].
Previous reports have demonstrated that Borrelia species
cannot reach high cell densities in vitro when cultured
without free GlcNAc [6,9]. Recent reports by Tilly et al
[10,11] extended this work in B. burgdorferi with three sig-
nificant findings. First, they observed that spirochetes cul-
tured without free GlcNAc exhibit biphasic growth when
the culture is followed for an extended period of time (up
to 200 hours). Following an initial log phase, the cells
bleb and enter a death phase before recovering and enter-
ing a second exponential phase [10]. Second, Tilly et al
[10] demonstrated that cells cultured without free Glc-
NAc, but supplemented with chitobiose, exhibit normal
growth and reach high cell densities. Based on these
results they hypothesized that the second exponential
phase might be due to the import of chitobiose via a phos-
photransferase system (PTS) encoded by three genes
(BBB04, BBB05 and BBB06) on circular plasmid 26
(cp26). Annotation of the genome sequence originally
identified this group of genes (celB, celC and celA) as a cel-
lobiose (dimer subunit of cellulose) transport system.
However, functional analysis of BBB04 (celB) by Tilly et al
[10,11] revealed that this group of genes is responsible for
the import of chitobiose. Based on these findings they
proposed renaming this set of genes, with BBB04 (celB),
BBB05 (celC) and BBB06 (celA) now designated chbC,
chbA and chbB, respectively [10]. We have adopted this
nomenclature for this communication. Finally, Tilly et al
[11] demonstrated that a chbC mutant can be maintained
in ticks and mice, and that the mutation of this gene does
not affect transmission of spirochetes. While these results
suggest that chbC is not essential for virulence of B. burg-
dorferi, the studies were conducted in pathogen-free ticks
and mice in a controlled laboratory environment. We
hypothesize that chbC may still play an important role for
survival of spirochetes in a natural setting, as ticks are
often infected with more than one pathogen [12] and
chbC may be important for B. burgdorferi to compete with
other microorganisms to colonize the tick midgut. There-
fore, this study was conducted to further investigate the
regulation of chbC.
Alternative sigma factors are an important mechanism
used by many bacteria to regulate gene expression, and
can coordinate the expression of multiple genes needed to
adapt to a variety of stresses [13]. B. burgdorferi encounters
differences in temperature, pH and nutrient availability as
it cycles between vector and host. Substantial investiga-
tion has focused on the differential expression of genes
key to colonization, survival, and transmission of spiro-
chetes during its enzootic life cycle [14,15]. Examination
of the B. burgdorferi genome reveals this organism pos-
sesses only two genes that encode for alternative sigma
factors, BB0771 (rpoS) and BB0450 (rpoN) [16]. Studies
have demonstrated that these two sigma factors regulate
the expression of numerous genes in different environ-
ments, and are essential for colonization and survival inBMC Microbiology 2009, 9:108 http://www.biomedcentral.com/1471-2180/9/108
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both the tick and mammal [17-19]. In this investigation
we examine the role of RpoS and RpoN on biphasic
growth, the utilization of chitobiose, and the expression
of chbC in the absence of free GlcNAc.
Results
Effect of rpoS mutation on growth in BSK-II without 
GlcNAc
To determine if the alternative sigma factor, RpoS, is
involved in the regulation of biphasic growth, we com-
pared the growth of an rpoS mutant strain (A74) to a wild-
type strain (B31-A) in the presence and absence of free
GlcNAc (Fig. 1). Growth of B31-A and A74 were similar in
complete medium, although the wild-type strain reached
a slightly higher cell density of 8.6 × 107 cells ml-1 com-
pared to 3.2 × 107 cells ml-1 for the rpoS mutant. When
cells were cultured in the absence of free GlcNAc there was
a considerable difference in the ability of the two strains
to initiate a second exponential phase. Initially, both
strains grew from a starting cell density of 1.0 × 105 cells
ml-1 to ~2.5 × 106 cells ml-1 by 72 h before entering a death
phase characterized by a loss of motility and the forma-
tion of blebs near the cell midpoint (Fig. 2B and 2D). As
expected, the wild-type strain exhibited biphasic growth,
initiating a second exponential phase by 200 h and reach-
ing a peak cell density of 3.65 × 107 cells ml-1 by 290 h.
During the second exponential phase cells exhibited nor-
mal morphology characteristic of cells cultured in the
presence of GlcNAc (Fig. 2A and 2C). In contrast, the rpoS
mutant strain did not initiate a second exponential phase
by 381 h.
Similar growth experiments were conducted with the rpoS
complemented mutant, WC12, in an attempt to recover
the second exponential phase in A74 (Fig. 1). In complete
BSK-II, WC12 showed a growth rate similar to the wild-
type and rpoS mutant strains, and reached a peak cell den-
sity of 8.2 × 107 cells ml-1. When cultured in the absence
of free GlcNAc, WC12 exhibited a growth pattern similar
to the wild-type B31-A strain. The cells grew to 1.5 × 106
cells ml-1 by 72 h before entering the characteristic death
phase, and then initiated a second exponential phase by
200 h. Taken together, these results suggest that RpoS
plays a role in the initiation of the second exponential
phase when cells are cultured in the absence of free Glc-
Mutation of rpoS delays biphasic growth during GlcNAc star- vation Figure 1
Mutation of rpoS delays biphasic growth during Glc-
NAc starvation. Growth of B. burgdorferi strains B31-A 
(WT), A74 (rpoS mutant) and WC12 (rpoS complemented 
mutant) in BSK-II with GlcNAc (closed circle, B31-A; closed 
triangle, A74; closed square, WC12) and without GlcNAc 
(open circle B31-A; open triangle, A74; open square, WC12). 
Late-log phase cells from each strain were diluted to 1.0 × 
105 cells ml-1 in the appropriate medium, incubated at 33°C 
and enumerated daily as described in the Methods. This is a 
representative experiment that was repeated three times.
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Morphology of B. burgdorferi during GlcNAc starvation Figure 2
Morphology of B. burgdorferi during GlcNAc starva-
tion. Phase contrast microscopy of B. burgdorferi strain B31-
A at 400× (A and B) and 1000× (C and D). Spirochetes were 
cultured for 72 h in BSK-II with GlcNAc (A and C) and with-
out GlcNAc (B and D).
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NAc, possibly due to the regulation of genes important to
the process.
Effect of RpoS on the expression of chbC
Previously, Tilly et al [10] used Northern blot analysis to
demonstrate increased expression of chbC, the membrane-
spanning component of the chitobiose PTS transporter, in
the second exponential phase of wild-type cells cultured
in the absence of free GlcNAc. They also demonstrated
that mutation of the chbC gene resulted in a failure of the
cells to initiate a second exponential phase by 200 h [10].
From these data they concluded that chbC expression is
critical for initiation and growth of B. burgdorferi cells in
the second exponential phase when cultured in the
absence of free GlcNAc [10]. Since we have shown the rpoS
mutant failed to initiate a second exponential phase in the
absence of free GlcNAc by 381 h (Fig. 1), we hypothesized
that the rpoS mutant may not exhibit a second exponential
phase because RpoS is involved, directly or indirectly, in
the regulation of chbC transcription. To test this hypothe-
sis, RNA was collected from B31-A, A74 and WC12 at var-
ious times during growth in media lacking free GlcNAc,
and the expression of chbC was evaluated by real time
quantitative reverse transcription PCR (qRT-PCR) (Fig. 3).
Cells were collected for RNA extraction at 44 h after initi-
ation of the growth experiment and at various time points
thereafter. Fold differences in chbC expression were calcu-
lated by comparing expression at the various time points
to the expression at 44 h (Fig. 3). This time point was cho-
sen as the baseline as cells are still in the first exponential
phase and in the presence of residual free GlcNAc or chi-
tobiose from yeastolate or rabbit serum (see below). Prior
expression studies conducted by Tilly et al [10] demon-
strated that chbC levels remain low in the presence of free
GlcNAc. In addition, we evaluated the expression of chbC
in cells cultured in the absence of GlcNAc and supple-
mented with high or low concentrations of chitobiose
(data not shown). As in complete a medium, chbC expres-
sion levels remained low until chitobiose was exhausted
and cells became starved for GlcNAc (data not shown).
In wild-type cells, chbC levels increased by 22-fold at 195
h just as cells entered the second exponential phase.
Expression of chbC peaked with a 44-fold increase at 239
h, before declining as cells entered stationary phase. In
contrast, expression of chbC in the rpoS mutant did not
change from baseline levels for the first 340 h. However,
expression did increase by 6-fold at 381 h, which may cor-
respond to this strain beginning to enter a second expo-
nential phase after 400 h (Fig. 4B). When expression of
chbC  was evaluated in the rpoS  complemented mutant
(WC12), levels increased as cells entered the second expo-
nential phase similar to that observed in the wild type. A
27-fold increase was observed at 216 h as cells started to
grow in the second exponential phase, and expression
peaked with a 40-fold increase at 239 h before declining
as cells entered stationary phase. Statistical analysis was
performed to determine the significance of chbC expres-
sion between B31-A and A74 and between WC12 and
A74, and fold differences were determined to be statisti-
cally significant between 216 and 340 h (p < 0.001).
Effect of RpoS on chitobiose utilization
In order to evaluate the importance of RpoS in chitobiose
utilization, we compared growth of B31-A, A74 and
WC12 in BSK-II lacking GlcNAc and supplemented with
low (5 μM or 15 μM) or high (75 μM or 150 μM) concen-
trations of chitobiose (Fig. 4A–C). As expected from the
previous study [10], B31-A exhibited a single exponential
phase when cultured with a high concentration (150 μM)
of chitobiose, reaching a peak cell density of 7.8 × 107 cells
ml-1 by 166 h (Fig. 4A). In contrast, when B31-A was cul-
Mutation of rpoS delays the up regulation of chbC expression  during GlcNAc starvation Figure 3
Mutation of rpoS delays the up regulation of chbC 
expression during GlcNAc starvation. Growth of B. 
burgdorferi strains B31-A (WT), A74 (rpoS mutant), and 
WC12 (rpoS complemented mutant) in BSK-II without Glc-
NAc (closed circle, B31-A; closed triangle, A74; closed 
square, WC12) and expression of chbC transcript in each 
strain (open circle, B31-A; open triangle, A74; open square, 
WC12). Late-log phase cells from each strain were diluted to 
1.0 × 105 cells ml-1in BSK-II lacking GlcNAc, and RNA was 
extracted from each strain at various times during growth. 
Expression of chbC was determined by qRT-PCR and the fold 
change from the initial time point (44 h) was calculated. For 
expression analyses, duplicate measurements were per-
formed for two biological replicates. Error bars represent 
the standard error of the mean.
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tured with ten-fold less chitobiose (15 μM) biphasic
growth was observed. Biphasic growth in the presence of
15 μM chitobiose differed from that observed in cells cul-
tured without both free GlcNAc and chitobiose, as cells in
the first exponential phase grew to a density that was 6.3-
fold higher in the presence of low levels of chitobiose (1.6
× 107 cells ml-1) compared to no added chitobiose or Glc-
NAc (2.5 × 106 cells ml-1).
To determine if RpoS is required for chitobiose utiliza-
tion, we cultured A74 in BSK-II without GlcNAc and sup-
plemented with low (15 μM) or high (150 μM)
concentrations of chitobiose (Fig. 4B). In contrast to the
wild type, the rpoS mutant was initially unable to utilize
chitobiose at either concentration, as cells only grew to
2.0 × 106 cells ml-1 before blebbing and entering a death
phase. At about 200 h cells cultured in both low and high
concentrations of chitobiose entered a second exponen-
tial phase. In comparison to the wild type, these results
suggest that RpoS is important for chitobiose utilization,
as the rpoS mutant cultured in the absence of free GlcNAc
and supplemented with chitobiose could not initially uti-
lize free chitobiose as a source of GlcNAc. A74 cultured in
the presence of 150 μM chitobiose reached a peak cell
density after the second exponential phase of 4.8 × 107
cells ml-1 by 334 h before entering stationary phase. In
contrast, A74 cultured in the presence of 15 μM chitobiose
reached a peak density of 2.2 × 107 cells ml-1 at 287 hours
before blebbing and entering a second death phase in
which cell numbers declined to 1.5 × 105 cells ml-1. At 525
h, cells cultured with 15 μM chitobiose entered a third
exponential growth phase, and grew to a peak cell density
of 1.4 × 107 cells ml-1 before entering stationary phase.
With exception of the first death phase, these results are
consistent with those obtained for the wild type cultured
in 15 μM chitobiose, and further support our hypothesis
that the source of GlcNAc during growth in the second
exponential phase in the wild type, and the third expo-
nential phase in the rpoS mutant, is not free chitobiose.
Inspection of A74 growth without GlcNAc and without
chitobiose revealed triphasic growth similar to, though
less pronounced than, that observed in A74 cultured in 15
μM chitobiose (Fig. 4B). As expected, cells reached a den-
sity of 2.2 × 106 cells ml-1 in the first exponential phase
before blebbing and entering the first death phase. At 189
h the rpoS mutant entered a second exponential phase,
and reached a peak density of 6.5 × 105 cells ml-1 at 236 h.
This second exponential phase corresponds to that
observed when A74 is grown in the presence of chitobi-
ose, suggesting there is a small amount of free chitobiose
present in BSK-II. After a second death phase, cells entered
a third exponential phase at 385 h and reached a peak cell
density of 1.4 × 107 cells ml-1 at 574 h before entering sta-
tionary phase. This final exponential phase may explain
Mutation of rpoS delays chitobiose utilization Figure 4
Mutation of rpoS delays chitobiose utilization. Growth 
of B. burgdorferi strains (A) B31-A (WT), (B) A74 (rpoS 
mutant) and (C) WC12 (rpoS complemented mutant) in BSK-
II lacking GlcNAc (open circle) and supplemented with 1.5 
mM GlcNAc (closed circle), or high (closed triangle, 75 μM 
or 150 μM) or low (open triangle, 5 μM or 15 μM) concen-
trations of chitobiose. Late-log phase cells were diluted to 
1.0 × 105 cells ml-1 in the appropriate medium, incubated at 
33°C, and enumerated daily as described in the Methods. 
This is a representative experiment that was repeated three 
times.
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the slight increase in chbC expression observed by qRT-
PCR at 381 h (Fig. 3).
To confirm the role of RpoS in chitobiose utilization, we
evaluated the growth of the rpoS complemented mutant,
WC12, in BSK-II without GlcNAc and supplemented with
low (5 μM) and high (75 μM) concentrations of chitobi-
ose (Fig. 4C). As expected, growth of the complemented
mutant was similar to that observed for the wild type. In
the presence of high concentrations of chitobiose, the
complemented mutant exhibited a single exponential
phase and reached a peak density of 8.2 × 107 cells ml-1 by
117 h before entering stationary phase. In contrast, when
the complemented mutant was cultured with the low con-
centration (5 μM) of chitobiose biphasic growth was
observed. In the first exponential phase cells grew to a
peak cell density of 5.2 × 106 cells ml-1 at 96 h before bleb-
bing and entering a death phase. This was a 3.5-fold
higher cell density than that observed in the comple-
mented mutant cultured without GlcNAc and without
chitobiose. At 170 h the complemented mutant entered a
second exponential phase, which peaked at a cell density
of 1.5 × 107 cells ml-1. These results lend further support
to the hypothesis that RpoS plays a role in the utilization
of chitobiose.
Effect of RpoN on chitobiose utilization
Several reports have demonstrated that under certain con-
ditions  rpoS  expression is regulated directly by RpoN
[19,20]. To determine if RpoN plays a role in chitobiose
utilization, we generated an rpoN mutant in the B31-A
background (RR22) and evaluated its growth in BSK-II
lacking GlcNAc and supplemented with a high concentra-
tion of chitobiose (Fig. 5). In the complete medium, RR22
exhibited growth similar to the wild type, reaching a peak
cell density of 7.7 × 107 cells ml-1 by 172 hours. In BSK-II
lacking GlcNAc RR22 exhibited biphasic growth similar to
the wild type, as initiation of the second exponential
phase occurred at 235 hours. When cultured in a medium
lacking GlcNAc and supplemented with 75 μM chitobiose
RR22 exhibited only one exponential phase, and reached
a peak cell density of 8.6 × 107 cells ml-1 by 172 h. These
results suggest RpoN is not necessary for chitobiose utili-
zation. It is important to note that growth curves of the
rpoN mutant were conducted in parallel with the wild
type, rpoS mutant and rpoS complemented mutant growth
experiments (Fig. 4).
Identification of the chbC transcriptional start site and 
promoter analysis
The results above demonstrate that RpoS regulates the
expression of chbC, at least partially, and is important in
chitobiose utilization in vitro. To determine if the chbC
gene has a promoter similar to other RpoS-dependent
genes, we performed 5' RACE to identify the transcrip-
tional start site of chbC  and compared the promoter
region with previously described RpoD, RpoS and RpoN-
dependent promoter sequences in B. burgdorferi. Total
RNA was extracted from B31-A and used to generate chbC-
specific cDNA in a reverse transcription reaction. The
cDNA was purified and a homopolymeric dA-tail was
added. Subsequent PCR with the oligo dT-anchor primer
and a nested chbC-specific primer (BBB04 5' RACE R2)
resulted in an approximate 410 bp product (Fig. 6A; lane
2). The PCR product was sequenced, and the transcrip-
tional start site was determined to be between 42 and 44
base pairs upstream of the translational start site (Fig. 6B).
To resolve this ambiguity chbC-specific cDNA was tailed
with dGTP, and PCR was carried out using the oligo dC-
anchor primer and the nested chbC-specific primer. Sepa-
ration of this PCR by gel electrophoresis revealed two
products that were approximately 250 and 410 base pairs
(Fig. 6A; lane 3). The bands were gel extracted and
sequenced. Sequence analysis of the lower band showed
this product was from mispriming of the oligo dC-anchor
RpoN is not required for chitobiose utilization Figure 5
RpoN is not required for chitobiose utilization. 
Growth of B. burgdorferi strain RR22 in BSK-II lacking Glc-
NAc and supplemented with 75 μM chitobiose. Late-log 
phase cells were diluted to 1.0 × 105 cells ml-1 in the appro-
priate medium (closed circle, 1.5 mM GlcNAc; open circle, 
No addition, i.e. without GlcNAc; closed triangle, 75 μM chi-
tobiose), incubated at 33°C and enumerated daily as 
described in the Methods. This is a representative experi-
ment that was repeated three times.
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primer to three guanosines located 160 to 162 base pairs
downstream of the chbC translational start site (data not
shown). Comparison of the sequences from the upper
dG-tailed product (Fig. 6C) and the dA-tailed product
(Fig. 6B) revealed the chbC transcriptional start site 42
base pairs upstream of the translational start site.
Identification of the chbC transcriptional start site allowed
us to identify the -10 and -35 promoter regions by visual
inspection of the upstream sequence (Fig. 7). Further
analysis of the promoter region was conducted by com-
paring the putative chbC promoter to previously described
B. burgdorferi promoters controlled by RpoD, RpoS and
RpoN (Fig. 7). Recently, Caimano et al [21] evaluated the
RpoS regulon in B. burgdorferi by microarray and qRT-PCR
expression analysis and identified genes that were abso-
lutely RpoS-dependent as well as genes that were dually
transcribed by RpoS and at least one of the other sigma
factors in B. burgdorferi. Analysis of the promoter region
from ten absolutely RpoS-dependent genes allowed them
to identify a putative RpoS consensus -10 and -35
sequence (Fig. 7). In addition, they attempted to identify
the promoter regions for 10 dually transcribed genes, but
were only able to find putative promoter elements for five
of the genes which were highly similar to the consensus
sequence generated from the absolutely RpoS-dependent
genes. We used these five putative promoters to generate a
dually transcribed -10 and -35-consensus sequence for
comparison to our newly identified chbC promoter region
(Fig. 7), as results presented above strongly suggest that
this gene is dually regulated by RpoS and RpoD. Addition-
ally, we generated a consensus RpoD-dependent pro-
moter sequence for comparison (Fig. 7) based on seven
genes identified in the literature [22-27].
Determination of the chbC transcriptional start site Figure 6
Determination of the chbC transcriptional start site. The chbC transcriptional start site was determined by 5' RACE 
analysis. (A) One percent TAE agarose gel of the 5' RACE products. A 1 kb ladder was used as a size standard (lane 1) for com-
parison of 5' RACE products (lane 2, dA-tailed product; lane 3, dG-tailed product). (B) DNA sequence of the dA-tailed 5' 
RACE product showing the ambiguous chbC transcriptional start site (enlarged font). (C) DNA sequence of the dG-tailed 5' 
RACE product showing the chbC transcriptional start site (enlarged font). Sequences were determined using the anti-sense 
primer BBB04 5' RACE R2.
A.
-12…AACTAATTAA AAGTTATAAT TAATAACTTA CAATATTTAT TATAATA…-58 Upstream region of chbC
…AACTAATTAA AAGTTATAAT TAATAACTTA CAAAAAAAAA AAAAAAA… A-tailed 5’ RACE product
B.
200 bp
500 bp
C.
-12…AACTAATTAA AAGTTATAAT TAATAACTTA CAATATTTAT TATAATA…-58 Upstream region of chbC
…AACTAATTAA AAGTTATAAT TAATAACTTA CGGGGGGGGG GGGGGGG… G-tailed 5’ RACE product
1     2     3BMC Microbiology 2009, 9:108 http://www.biomedcentral.com/1471-2180/9/108
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Comparison of the chbC  promoter region to the abso-
lutely RpoS-dependent consensus or the dually tran-
scribed consensus sequences revealed the same
differences in four of the eleven extended -10 positions. In
contrast, there was only a one base difference between the
chbC extended -10 and that of the RpoD consensus pro-
moter (Fig. 7). As expected, the -35 consensus for the
RpoS and RpoD-dependent promoters were very similar,
and the sequence for the chbC -35 region only differed by
one base when compared to both consensus sequences.
Of note, the spacing between the end of the extended -10
and the beginning of the -35 sequences for the dually tran-
scribed genes ranged from 7 to 13 bases, whereas for
RpoD-dependent genes the spacing ranged from 11 to 13
bases. The predicted spacing between the extended -10
and -35 of the chbC promoter was 7 bases, which is similar
to at least 2 dually transcribed genes. Finally, the consen-
sus RpoN-dependent sequence is shown for comparison,
and there is no evidence of the GG and GC doublets in the
highly conserved -24/-12 regions of the chbC promoter
that are typically observed in genes directly controlled by
RpoN (Fig. 7) [28].
Growth of B. burgdorferi without yeastolate
Yeastolate, a component of BSK-II, is the water-soluble
portion of autolyzed Sacchromyces cerevisiae, and contains
a mixture of peptides, amino acids, vitamins and simple
and complex carbohydrates. As the preparation is derived
from yeast it likely contains chitobiose and/or longer Glc-
NAc oligomers available to B. burgdorferi as a source of
GlcNAc. Previously, Tilly et al [10] suggested that yeasto-
late was the source of GlcNAc for growth of the wild type
in the second exponential phase, as cells failed to exhibit
a second exponential phase by 250 hours when cultured
without GlcNAc and without yeastolate. However, we
hypothesized that yeastolate may not be the source of Glc-
NAc during the second exponential phase, since B. burg-
dorferi can utilize chitobiose in the absence of free GlcNAc
to maintain normal growth and reach optimal cell densi-
ties in a single exponential phase. To test this hypothesis
Identification of the chbC promoter Figure 7
Identification of the chbC promoter. Comparison of the chbC promoter region with consensus promoter sequences for 
RpoS, dually transcribed, and RpoD-dependent genes. Nucleotide positions of promoters from dually transcribed and RpoD-
dependent genes that match their respective consensus sequence are highlighted, and consensus sequences are boxed. The 
RpoN consensus sequence is also included for comparison, and the highly conserved GG and GC doublets at the -24 and -12 
regions are boxed.
Gene RBS Reference
T T G A a/t t/a T G g/a g/a A T A t/a A T T [21]
Dually transcribed genes -18 -17 -16 -15 -14 -13 -12 -11 -10 -9 -8
bb0588 TTGAAC- 1 3 -TGAGGTATGTT -186- AGGA [21]
bb0680 TTGAGA- 1 3 -TGCTGTAAATT-56- GAGG [21]
bb0729-0728 TTAAGT- 1 1 -TGCACTAAGCT -7- GAGG [21]
bb0021 TTGATG - 8 - AGAAATATTTT -154- GAGG [21]
bb0548 TTGGAT - 7 -ATTACTTAATT -246- GGAG
a [21]
T T G A g/a N t/a G a/c A c/g T A a/t a/g T T This Study
chbC promoter
bbb04 TTGAGA - 7 - TATATTATAAT-38- GAGG This Study
RpoD-dependent genes
ospE TTGCAA- 1 1 -TGTGGTACTAT-10- AGGAG [22]
flaB TTCTTT- 1 2 -TGTGCTATTCT-51- GAGG [23]
bb0180 (flgK operon) TTGTAA- 1 2 -TAGCTTATAAT-56- AAGAA [23]
flaA TTAAAG- 1 2 -TAAATTAAATT-51- AAGGAG [24]
flgB CGAACA- 1 3 -TATTATATAAT-22- AGGGAGG [25]
secA-sodA TTTAAA- 1 2 -CATGATATAAT-87- AGGAGA [26]
bb0374 TAGACA- 1 2 -TATGATATACA-22- AGGGA [27]
T T g/a a/t a/c A T A T G a/t T A T A a/c T This Study
RpoN-dependent consensus TGGCAC N NNNNTTGCW [ 2 8 ]
-24 -12
Extended -10 Region
RpoD-dependent consesus
Absolutely RpoS-dependent 
consensus
Dually transcribed 
consensus
-35 RegionBMC Microbiology 2009, 9:108 http://www.biomedcentral.com/1471-2180/9/108
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we followed growth of wild-type cells in BSK-II without
free GlcNAc and yeastolate for an extended period of time
(Fig. 8). In contrast to the previous report, biphasic
growth was observed in cells cultured without GlcNAc
and yeastolate, suggesting that the source of GlcNAc for
growth in the second exponential phase was not chitobi-
ose or GlcNAc oligomers present in yeastolate. Addition-
ally, cells cultured without GlcNAc and yeastolate reached
a peak cell density of 9.0 × 105 cells ml-1 in the first expo-
nential phase prior to entering a death phase at 93 hours.
This was approximately 2-fold lower than that reached in
cells cultured without free GlcNAc only. This suggests that
cells cultured in the absence of free GlcNAc with yeasto-
late exhausted the residual free GlcNAc and/or GlcNAc
oligomers present in yeastolate before declining in den-
sity. A second exponential phase was observed in the cul-
ture without GlcNAc and yeastolate beginning at 266
hours, reaching a peak cell density of 3.0 × 107 cells ml-1
at 434 hours before entering stationary phase. Further-
more, when chitobiose was added to cells cultured with-
out GlcNAc and yeastolate a single exponential phase was
observed, though the growth rate was slightly reduced.
Taken together, these data suggest that the source of Glc-
NAc in the second exponential phase is due to compo-
nents in BSK-II other than yeastolate.
Discussion
In the present study we evaluated the role of RpoS and
RpoN on biphasic growth and chitobiose utilization in B.
burgdorferi cells cultured in the absence of free GlcNAc.
RpoS and RpoN are the only two alternative sigma factors
encoded by B. burgdorferi, and have been shown to play
key roles in the regulation of genes necessary for coloniza-
tion of both the tick vector and mammalian host [17-
19,29]. A previous report demonstrated that biphasic
growth in a medium lacking free GlcNAc is dependent on
chbC expression, as chbC transcript levels in wild-type cells
were increased during the second exponential phase [10].
We added to those results here by demonstrating that
RpoS in the B31-A background regulates biphasic growth,
as initiation of the second exponential phase was delayed
by more than 200 h in the rpoS mutant when compared to
the wild type and rpoS complemented mutant (Figs. 1 and
4A–C). Our results also suggest the delay in the rpoS
mutant is due, at least in part, to its inability to up regulate
chbC before 340 h during GlcNAc starvation (Fig. 3). In
contrast, chbC transcript levels increased in the wild type
and rpoS complemented mutant, corresponding to the ini-
tiation of a second exponential phase in these strains (Fig.
3). Taken together, these results confirm the requirement
for chbC expression during growth in the second exponen-
tial phase [10], and suggest that RpoS regulates biphasic
growth in media lacking free GlcNAc through regulation
of chbC transcription.
Tilly et al [10] previously demonstrated that wild-type B.
burgdorferi can efficiently transport and utilize chitobiose
in the absence of free GlcNAc to grow to optimal cell den-
sities in one exponential phase, with optimal growth
occurring at chitobiose concentrations ≥ 18 μM. We con-
firmed those observations and also demonstrated that B.
burgdorferi exhibits biphasic growth when cultured with
low concentrations (≤ 15 μM) of chitobiose (Fig. 4A). This
observation suggests that free chitobiose, and potentially
longer free GlcNAc oligomers, are not the source of Glc-
NAc for growth in the second exponential phase, as was
previously suggested [10]. In fact, growth of the wild type
without GlcNAc but supplemented with longer GlcNAc
oligomers, chitotriose and chitohexose, results in optimal
cell densities and only one exponential phase (Rhodes
and Nelson, manuscript in preparation). This observation
suggests that B. burgdorferi employs one or more enzymes
for the breakdown of longer GlcNAc oligomers, and that
this mechanism of obtaining sequestered (or bound) Glc-
Growth of B. burgdorferi strain B31-A in BSK-II without Glc- NAc and yeastolate, and supplemented with 150 μM chitobi- ose Figure 8
Growth of B. burgdorferi strain B31-A in BSK-II with-
out GlcNAc and yeastolate, and supplemented with 
150 μM chitobiose. Late-log phase cells were diluted to 1.0 
× 105 cells ml-1 in the appropriate medium (closed circle, 1.5 
mM GlcNAc, with Yeastolate; open circle, without GlcNAc, 
with Yeastolate; open triangle, without GlcNAc, without 
Yeastolate; closed triangle, without GlcNAc, without Yeasto-
late, with 150 μM chitobiose), incubated at 33°C, and enu-
merated daily as described in the Methods. This is a 
representative experiment that was repeated three times.
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NAc in the form of chitin is turned on during the first
exponential phase.
Chitin and chitobiose may serve as an important nutrient
source during the tick molt, as the peritrophic membrane
encasing the blood meal is turned over and GlcNAc oli-
gomers are released [8]. Previous laboratory studies by
Tilly et al [11] demonstrated that chbC is not necessary for
B. burgdorferi to complete an infectious cycle, leading
them to suggest that the genome is still evolving and
retains non-essential functional genes. However, we argue
that selective pressure must be involved in the retention of
this three component PTS, as it is also found in other Bor-
relia species (garinii and afzelli) that cause Lyme borrelio-
sis and to our knowledge there has not been a strain
isolated in which this transport system is not present. This
may be an instance in which mixed infection studies
would be appropriate to determine the competitive index
(i.e. degree of virulence attenuation) for the chbC mutant
as compared to the wild type.
To further demonstrate that free chitobiose or longer Glc-
NAc oligomers are not the source of GlcNAc in the second
exponential phase, we followed the growth of cells in a
medium lacking free GlcNAc and yeastolate (Fig. 8). Yeas-
tolate is the only component of BSK-II that may contain
GlcNAc oligomers, as it is derived from an organism with
a chitinous cell wall. Tilly et al [10] previously reported
that there was no second exponential phase by 250 hours
when cells were cultured without free GlcNAc and yeasto-
late, and therefore, suggested that chitobiose and possibly
other GlcNAc oligomers present in yeastolate may be the
source of GlcNAc for growth in the second exponential
phase. However, our results demonstrate that wild-type
cells do exhibit a second exponential phase in the absence
of free GlcNAc and yeastolate, and reach a peak cell den-
sity in the second exponential phase by 434 hours. This
result suggests yeastolate alone is not the source of Glc-
NAc for growth in the second exponential phase.
One possible explanation for the biphasic growth
observed in the absence of free GlcNAc or limiting
amounts of chitobiose is that a mutation has occurred
allowing for the outgrowth of a mutant population. A pre-
vious report from Tilly et al [10] suggested this was not the
case as cells back-diluted from the second exponential
phase into a medium without GlcNAc still exhibited
biphasic growth. However, in that experiment cells that
were back-diluted grew almost 10-fold higher in the first
exponential phase compared to cells in the first exponen-
tial phase from the original culture. This suggests the back-
diluted cells were now able to utilize a GlcNAc-containing
medium component that they were not previously able to
use. In fact, unpublished data from our laboratory sup-
ports the hypothesis (Rhodes and Nelson, manuscript in
preparation) that neopeptone (an enzymatic digest of
protein) and rabbit serum supply GlcNAc sequestered in
the form of glycoproteins or proteoglycans that B. burgdor-
feri can acquire and utilize for growth in the second expo-
nential phase. Numerous reports have demonstrated
adhesion of B. burgdorferi to mammalian cells through the
binding of glycoproteins such as fibronectin [30], gly-
cosaminoglycans such as heparin sulfate [31], and prote-
oglycans such as decorin [32]. The ability to bind these
substrates brings the spirochetes into close proximity with
bound GlcNAc, and may represent a valuable source of
this sugar when free GlcNAc or GlcNAc oligomers are not
available. A deglycosylation mechanism has recently been
described in Streptococcus pneumoniae, in which exogly-
cosidases sequentially remove sugar residues from host
glycoproteins [33]. We suggest that B. burgdorferi may
employ similar mechanisms by which they can release
and utilize bound GlcNAc from host-derived glycopro-
teins, glycosaminoglycans and/or proteoglycans. Results
Table 1: Strains and Plasmids
Strain or Plasmid Genotype and Description Reference
Strains
B. burgdorferi
B31-A High passage non-infectious wild-type [38]
A74 CoumR; B31-A rpoS mutant [38]
WC12 CoumR KanR; A74 complemented with rpoSBb/pCE320 This study
297 rpoN EryR; 297 rpoN mutant [19]
RR22 EryR; B31-A rpoN mutant This study
E. coli
DH5α supE44 F- ΔlacU169 (ϕ80lacZ ΔM15) hsdR17 relA1 endA1 gyrA96 thi-1 relA1[ 4 0 ]
Plasmids
rpoSBb/pCE320 KanR ZeoR; Pnat-rpoS [17]
pBB0450.1 AmpR EryR; ermC::rpoN This studyBMC Microbiology 2009, 9:108 http://www.biomedcentral.com/1471-2180/9/108
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described above suggest that some, if not all, of the Glc-
NAc imported into the cell in the second exponential
phase comes in the form of chitobiose. The proposed
mechanism for obtaining GlcNAc from glycoproteins
would be consistent with this as the oligosaccharide por-
tion of N-linked glycoproteins is attached to the amino
acid asparagine through chitobiose [34]. This core chito-
biose residue as well as others present throughout the oli-
gosaccharide moiety may be sources of GlcNAc for B.
burgdorferi  during growth in the second exponential
phase.
A second possible explanation for biphasic growth is that
it is the result of scavenging of GlcNAc released from dead
B. burgdorferi cells. While it cannot be ruled out that some
growth in the second exponential phase may be due to
scavenging of GlcNAc from dead cells, it is unlikely that
all of the growth is due to scavenging as the peak cell den-
sity in the second exponential phase is > 5-fold higher
than the cell density reached in the first exponential
phase. Therefore, there would not be a sufficient amount
of GlcNAc present in dead cells to account for the cell den-
sity reached in the second exponential phase. This point
was made previously by Tilly et al [10].
Since our experiments with the A74 rpoS mutant strongly
suggest that RpoS plays an important role in biphasic
growth and chbC expression in the B31-A background in
the absence of free GlcNAc, we also evaluated the ability
of the rpoS mutant to utilize free chitobiose. Unlike the
wild type (Fig. 4A) and rpoS complemented mutant (Fig.
4C), the rpoS mutant could not utilize chitobiose initially
and did not show chitobiose-stimulated growth until 200
h (Fig. 4B). The rpoS mutant began a second exponential
phase at 200 h with or without the addition of free chito-
biose (Fig. 4B), and triphasic growth was observed in the
absence of free GlcNAc and chitobiose. These results indi-
cate there is a small amount of free chitobiose present in
BSK-II, most likely as a component of the yeastolate or
rabbit serum. The addition of a low (15 μM) concentra-
tion of free chitobiose also resulted in triphasic growth
(Fig. 4B), but in this case growth in the second exponen-
tial phase was more than 30-fold higher when compared
to culturing the rpoS mutant in the absence of free GlcNAc
and chitobiose. Together, these results strongly suggest
that RpoS, at least partially, regulates chitobiose utiliza-
tion, and further demonstrate that free chitobiose is not
the source of GlcNAc in the second exponential phase of
the wild type or the third exponential phase of the rpoS
mutant.
Previous reports have demonstrated that a RpoN-RpoS
cascade regulates the expression of outer membrane lipo-
proteins, such as OspC and Mlps (multicopy lipopro-
teins), in B. burgdorferi [19,20,35]. Therefore, we
generated a high-passage B31-A rpoN mutant to determine
if RpoN is involved in the regulation of chitobiose utiliza-
tion. We were surprised to discover that our rpoN mutant
behaved similarly to the wild type, exhibiting only one
exponential phase when cultured without GlcNAc and
supplemented with 75 μM chitobiose (Fig. 5). This result
suggests that RpoN is not involved in the utilization of
free chitobiose, and therefore this pathway appears to be
regulated by only RpoS and RpoD. While our results do
seem to challenge the well established RpoN-RpoS para-
digm in B. burgdorferi, our experiments were performed
under different conditions. Typically, RpoS-dependent
genes are evaluated in vitro in a temperature-dependent
manner where cultures are shifted from 23°C to 35°C
[17,21]. However, our experiments were conducted exclu-
sively at 33°C as we observed a change in the phenotype
of the rpoS mutant at this temperature (biphasic growth
and decreased chbC  expression) that could be restored
when the wild-type gene was re-introduced on a plasmid.
In addition, we are not the first group to demonstrate
RpoS regulation in the absence of RpoN. Despite evidence
of direct regulation of rpoS by RpoN [20], Fisher et al [18]
also showed that RpoS can regulate genes in the absence
of RpoN. It is interesting to note that in this microarray
study BBB05 and BBB06 (chbA  and  chbB, respectively)
declined by 40–50% in a rpoN mutant. No changes in
BBB04, BBB05, or BBB06 transcription were reported for
their rpoS mutant. However, in that study, Fisher et al [18]
did not starve cells for GlcNAc, a technique that in our
hands results in a modest 2-fold increase in rpoS transcript
levels (data not shown), and a corresponding increase in
chbC expression (Fig. 3). Additionally, Lybecker and Sam-
uels [36] recently demonstrated that two rpoS transcripts
exist, a shorter RpoN-regulated transcript previously iden-
tified by Smith et al. [20] that predominates at high cell
density, and a longer transcript that does not possess the
canonical RpoN-dependent promoter whose translation
is regulated by the small RNA (sRNA) DsrABb at low cell
density.
Our physiological and molecular data evaluating chitobi-
ose utilization (Fig. 4) and chbC expression (Fig. 3) in the
wild type versus the rpoS mutant strongly suggests that
RpoD and RpoS both regulate chitobiose transport. To
determine if the chbC gene has a promoter similar to other
RpoS-dependent genes we identified the transcriptional
start site (Fig. 6) and the putative chbC promoter (Fig. 7).
While not conclusive, it is possible that regulation of chbC
by RpoS is through direct binding to the promoter region
as the spacing between the -10 and -35 consensus
sequences is similar to that of two of the dually tran-
scribed promoters (Fig. 7). On the other hand, the
sequence of the extended -10 chbC promoter element is
more like that of the predicted RpoD consensus, and it has
been shown that the extended -10 element plays a signifi-
cant role in sigma factor selectivity in B. burgdorferi [37].
Therefore, it cannot be ruled out that RpoS regulates chbCBMC Microbiology 2009, 9:108 http://www.biomedcentral.com/1471-2180/9/108
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expression indirectly through an unknown regulator,
rather than through direct binding and transcription from
the chbC promoter.
Conclusion
In this study we used a physiologic and molecular
approach to demonstrate that chitobiose utilization and
chbC expression are dually regulated by RpoD and RpoS.
We determined the chbC  transcriptional start site, and
identified the putative promoter region. Finally, we pro-
vided evidence that the second exponential phase
observed in cells cultured in the absence of free GlcNAc is
not due to components found in yeastolate, and suggest
that the source of GlcNAc in the second exponential phase
is sequestered in components of serum and/or neopep-
tone.
Methods
Bacterial strains and culture conditions
Wild-type  B. burgdorferi strain B31-A and rpoS  mutant
strain A74 were generously provided by Patricia Rosa [38].
All strains were routinely cultured in modified BSK-II
medium supplemented with 7% rabbit serum (Invitrogen
Corp., Carlsbad, CA) [6]. BSK-II was modified by the
replacement of 10× CMRL-1066 with 10× Media 199
(Invitrogen Corp.). The rpoS mutant (A74) and comple-
mented  rpoS  mutant (WC12) were maintained under
selection in BSK-II with either coumermycin A1 (0.5 μg
ml-1; A74) or both coumermycin A1 (0.5 μg ml-1) and
kanamycin (340 μg ml-1; WC12). The rpoN  mutant
(RR22) was maintained under selection in BSK-II with
erythromycin (0.6 μg ml-1). See Table 1 for a summary of
strains and plasmids used in this study.
Growth Curves
For growth experiments, late-log phase cells (~5.0 × 107
cells ml-1) were back-diluted to 1.0 × 105 cells ml-1 in 12
ml of BSK-II lacking GlcNAc or yeastolate, or lacking both
GlcNAc and yeastolate. Typically, 12–24 μl of culture was
inoculated into 12 ml of fresh medium; therefore, mini-
mal amounts of nutrients were transferred with the inoc-
ulum. Cultures were supplemented with 1.5 mM GlcNAc
(US Biochemical, Corp., Cleveland, OH), a low concen-
tration of chitobiose (5 or 15 μM; V-Labs, Inc., Covington,
LA) or a high concentration of chitobiose (75 or 150 μM).
All growth experiments were conducted at 33°C in the
presence of 3% CO2. Cells were enumerated daily by dark-
field microscopy using a Petroff-Hausser counting cham-
ber (Hausser Scientific, Horsham, PA). Specifically, 2.5 μl
of undiluted culture was transferred to the counting
chamber and cells were counted in all 25 squares. Once
cells reached a density >1.0 × 107 cells ml-1 the culture was
diluted 1:10 in BSK-II prior to enumeration. Each growth
curve is representative of at least three independent trials.
Growth data from independent experiments could not be
pooled due to the length of the experiments and the dif-
ferent times at which bacteria were enumerated.
Complementation of the B. burgdorferi rpoS mutation
A complemented rpoS mutant of A74 was generated using
rpoSBb/pCE320 (donated by Justin Radolf) [17], which
consists of the wild-type rpoS gene under the control of its
natural promoter. The plasmid contains a kanamycin
resistance gene under the control of the constitutive flgB
promoter, and was maintained in E. coli DH5α grown in
lysogeny broth (LB; 1% tryptone, 0.5% yeast extract, 1%
NaCl) supplemented with kanamycin (50 μg μl-1). The
QIAprep Spin Mini Kit (Qiagen, Inc., Valencia, CA) was
used to extract plasmid according to the manufacturer's
instructions. Plasmid rpoSBb/pCE320 was concentrated to
greater than 1 μg μl-1, and 10 μg of plasmid was trans-
formed into competent A74. Cells from the transforma-
tion reaction were resuspended in 10 ml of BSK-II
containing 20 μg ml-1  phosphomycin, 50 μg ml-1
rifampicin and 2.5 μg ml-1 amphotericin B (Antibiotic
Mixture for Borrelia 100x; Sigma-Aldrich, St. Louis, MO),
and allowed to recover for 18–24 h before plating in BSK-
II containing kanamycin (340 μg ml-1) according to the
protocol of Samuels et al [39]. Kanamycin resistant colo-
nies, appearing approximately 10–14 days after plating,
were screened for the presence of the complementation
plasmid by PCR using primers BB0771 F1 and BB0771 R1
2. A positive clone was chosen for further experiments and
designated WC12.
Construction of the rpoN mutant in B31-A
A  B. burgdorferi 297  rpoN  mutant strain (donated by
Michael Norgard) [19], in which rpoN was interrupted by
the insertion of an erythromycin resistance gene, was
maintained in BSK-II containing erythromycin (0.6 μg ml-
1). Genomic DNA was extracted from the 297 rpoN
mutant using the DNeasy Tissue Kit (Qiagen, Inc.) follow-
ing the manufacturer's instructions. Primers BB0450
mutF1 and BB0450 mutR1 (Table 2) were used to PCR
amplify  rpoN::ermC  and flanking DNA from 297 rpoN
mutant genomic DNA. The PCR product (~4.4 kb) was TA
cloned into the pGEM T-Easy vector (Promega, Corp.,
Madison, WI) according to the manufacturer's instruc-
tions, and the ligation reaction was transformed into com-
petent  E. coli DH5α. A transformant containing the
plasmid of interest was selected by blue-white screening
on LB containing ampicillin (200 μg ml-1) and X-gal (40
μg ml-1), confirmed by PCR using the BB0450 mutF1 and
BB0450 mutR1 primers, and designated pBB0450.1.  See
Table 2. The plasmid was extracted and concentrated to
greater than 1 μg μl-1, and 10 μg were transformed into
competent B31-A as described above. Transformants were
selected by plating on BSK-II containing erythromycin
(0.6 μg/ml) according to the protocol of Samuels et al
[39]. The mutation in the rpoN gene of B31-A was con-BMC Microbiology 2009, 9:108 http://www.biomedcentral.com/1471-2180/9/108
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firmed by PCR using primers flanking the ermC insertion
site (BB0450 mut confirm F1 and BB0450 mut confirm
R1.  See Table 2), and the mutant was designated RR22. In
addition, DNA sequence analysis (ABI Prism® 3130XL
Genetic Analyzer, Applied Biosystems, Forest City, CA)
was performed to verify the rpoN::ermC junctions using
primers 5' ermC seq out and 3' ermC seq out.  See Table
2. The University of Rhode Island Genomics and Sequenc-
ing Center performed DNA sequencing.
RNA extraction
Cells were harvested at various times during growth by
centrifugation (10,000 × g, 12 min, 4°C). Pellets were
resuspended in 500 μl of BSK-II lacking GlcNAc and trans-
ferred to 2 ml microcentrifuge tubes. One ml of Bacteria
RNAProtect (Qiagen, Inc.) was added and mixed by vor-
texing. Cells were incubated for 5 min at room tempera-
ture, and then centrifuged for 10 min at 5,000 × g. Pellets
were stored at -80°C for up to 4 weeks prior to RNA
extraction. RNA was extracted using the RNeasy Mini kit
(Qiagen, Inc.) according to the manufacturer's instruc-
tions. RNA was DNase-treated with RQ1 RNase-free
DNase (Promega Corp.), and RNasin (Promega Corp.)
was added according to the manufacturer's instructions.
Protein from the DNase reaction was removed using the
RNeasy Mini kit according to the RNA Cleanup protocol
supplied by the manufacturer. RNA concentration
(OD260) and purity (OD260/OD280) were determined by
UV spectrophotometry. RNA integrity was evaluated by
gel electrophoresis. Specifically, 2 μg of each sample was
separated on a 1% agarose gel and the intensity of the 16S
and 23S ribosomal RNA bands was determined. RNA was
stored at -80°C for subsequent gene expression analysis.
Real-time quantitative reverse transcription-PCR (qRT-
PCR)
qRT-PCR was performed using the Mx4000 or Mx3005P
Multiplex Quantitative PCR System and the Brilliant SYBR
Green Single-Step qRT-PCR Master Mix Kit (Stratagene, La
Jolla, CA) according to the manufacturer's instructions. A
standard curve (101 to 107 copies per reaction) was gener-
ated using a purified chbC PCR product as the template.
The following primers were used for all reactions: forward
primer chbC F and reverse primer chbC R. Reactions (25
μl) containing 10 ng of total RNA were run under the fol-
lowing conditions: 1 cycle of 50°C for 30 min and 95°C
for 15 min, followed by 40 cycles of 95°C for 30 s and
58°C for 30 s 2. Fluorescence was measured at the end of
the 58°C step every cycle. Samples were run in duplicate,
and all qRT-PCR experiments included both no-reverse
transcriptase (RT) and no-template controls. The copy
number of chbC mRNA in each sample was determined
using the MxPro (Stratagene) data analysis software based
on the chbC standard curve described above. The chbC
copy number for each sample was normalized based on
the total RNA input (10 ng per reaction), and fold differ-
ences in chbC expression from the initial time point (44 h)
were calculated based on the normalized copy numbers.
Identification of the chbC transcriptional start site and 
promoter analysis
Total RNA was isolated from wild-type B. burgdorferi strain
B31-A cultured in complete BSK-II as described above.
The transcriptional start site was determined using the 2nd
Generation 5'/3' RACE Kit (Roche Applied Science; Man-
nheim, Germany) according to the manufacturer's
instructions. Briefly, first-strand cDNA synthesis was car-
ried out in a reverse transcription reaction for 60 min at
55°C using primer BBB04 5' RACE R1 2 and 1 μg of total
RNA. The chbC-specific cDNA was purified using the High
Pure PCR Product Purification Kit (Roche Applied Sci-
ence). The resulting purified cDNA was split to two reac-
tion tubes and a homopolymeric A or G-tail was added to
the 3' end using recombinant terminal deoxynucleotidyl
transferase and dATP or dGTP. A PCR product was ampli-
fied from each tailed cDNA using the appropriate anchor
Table 2: Oligonucleotide primers
Primer Name Sequence (5'→3')
BB0771 F1 CTTGCAGGACAAATACAAAGAGGC
BB0771 R1 GCAGCTCTTATTAATCCCAAGTTGCC
BB0450 mutF1 TTCTCCTCTTGGAACCATTCCGGT
BB0450 mutR1 ACCATAACCTACCACGCCCTCAAT
BB0450 mut confirm F1 GGTTCCATAATATGTTCTCCCTTTCTCAG
BB0450 mut confirm R1 CCCAACGCTCGAATTTAAAGACCC
5' ErmC seq out GGCCTTTTCCTGAGCCGATTTCAAAG
3' ErmC seq out TTCCTTAAAACATGCAGGAATTGACG
chbC F GGGAATTCAGCCCAATTCATGGTTTCC
chbC R GGCGGAACAGACTCTGGAAGCTTAAT
BBB04 5'RACE R1 GCTACAATTGAAAGCGCAACAACAGG
Oligo(dT) AP GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTTV
Oligo(dC) AP GACCACGCGTATCGATGTCGACCCCCCCCCCCCCCCCC
BBB04 5'RACE R2 AGCAGCATCTCCACCGTAAGGTATBMC Microbiology 2009, 9:108 http://www.biomedcentral.com/1471-2180/9/108
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primer (oligo dT-AP or oligo dC-AP) and the nested gene
specific primer BBB04 5' RACE R2 2. The PCR products
were subjected to electrophoresis and the bands were gel
extracted using the QIAquick PCR Purification Kit (Qia-
gen). The sequence of the purified PCR products was
determined using the BBB04 5' RACE R2 primer and
aligned to the upstream sequence of chbC to determine
the transcriptional start site. Promoter analysis was carried
out by visual inspection and comparison of the region
upstream of the chbC transcriptional start site with previ-
ously described RpoD, RpoS and RpoN-dependent pro-
moter sequences in B. burgdorferi.
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